No Data
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○ List of stocks with sell conversion Market Code Stock name Closing price SAR main board <1780> Yamauura 1155 1212 <1815> Tekken 22732438 <1911> Sumitomo Forestry 54995940 <2109> DM Mitsui Sugar 32003305 <2198> Ikikei 732742 <2371> Kakaku.com 24062694 <2440> Gurunavi 305333 <2445> Takami
Chugoku Marine Paints: Confirmatory letter.
Chugoku Marine Paints: Semi-Annual Report - Term 128 (2024/04/01 - 2025/03/31)
Stocks that moved the previous day part1 mitsubishi electric corp. unsponsored adr, FPG, Makino Milling Machine Co., Ltd., etc.
Stock Name <Code> Closing Price on 1st Day → Day Before Comparison Asahi Kasei <3407> 1127 +67.5 First-half Operating Profit increased by 94.9%. Also announced a share buyback of up to 2.52% of the issued shares. Mabuchi Motor <6592> 2311 +115 Third Quarter Cumulative Operating Profit increased by 80.8%. Kurimoto Iron <5602> 4075 +250 Net profit for the fiscal year ending March 2025 and dividends forecast have been upwardly revised. J-Power <9513> 2634 +81.5 Fiscal year ending March 2025 performance forecast has been revised upward. Rengo <3941>
China Paint - 2Q operating profit increased by 54.6% to 7.929 billion yen, upward revision for the 25/3 period.
In the second quarter of the fiscal year ending March 2025, revenue increased by 13.6% year-on-year to 62.935 billion yen, and operating profit increased by 54.6% to 7.929 billion yen. In the marine paint sector, sales increased overall due to a significant increase in shipping volume mainly in South Korea for new ship construction, and the adjustment of selling prices in line with manufacturing costs. Additionally, a revision of the financial estimates for the fiscal year ending March 2025 was announced, with an upward revision of operating profit from 12 billion yen to 15 billion yen.
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-spons adr <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, and operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased to 47.8%, surpassing the same period last year by 0.8 points, due to cost reductions and improvements in product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. Positive evaluation for Takeda Pharmaceutical Co., Ltd. <4502> in the mid-term and Sony Corporation <7735>.
No Data
No Data